- Home
- LSTA vs PIII Comparison
LSTA vs PIII Comparison
Compare LSTA & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- PIII
- Stock Information
- Founded
- LSTA 1980
- PIII 2015
- Country
- LSTA United States
- PIII United States
- Employees
- LSTA 26
- PIII N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- PIII Medical/Nursing Services
- Sector
- LSTA Health Care
- PIII Health Care
- Exchange
- LSTA Nasdaq
- PIII Nasdaq
- Market Cap
- LSTA 22.5M
- PIII 21.4M
- IPO Year
- LSTA N/A
- PIII N/A
- Fundamental
- Price
- LSTA $2.72
- PIII $6.23
- Analyst Decision
- LSTA Strong Buy
- PIII Buy
- Analyst Count
- LSTA 1
- PIII 2
- Target Price
- LSTA $15.00
- PIII $16.25
- AVG Volume (30 Days)
- LSTA 23.4K
- PIII 3.7K
- Earning Date
- LSTA 08-11-2025
- PIII 08-06-2025
- Dividend Yield
- LSTA N/A
- PIII N/A
- EPS Growth
- LSTA N/A
- PIII N/A
- EPS
- LSTA N/A
- PIII N/A
- Revenue
- LSTA $1,000,000.00
- PIII $1,485,192,000.00
- Revenue This Year
- LSTA N/A
- PIII N/A
- Revenue Next Year
- LSTA N/A
- PIII $6.01
- P/E Ratio
- LSTA N/A
- PIII N/A
- Revenue Growth
- LSTA N/A
- PIII 9.79
- 52 Week Low
- LSTA $1.87
- PIII $6.00
- 52 Week High
- LSTA $4.20
- PIII $32.54
- Technical
- Relative Strength Index (RSI)
- LSTA 52.43
- PIII 42.33
- Support Level
- LSTA $2.34
- PIII $6.00
- Resistance Level
- LSTA $3.09
- PIII $6.46
- Average True Range (ATR)
- LSTA 0.25
- PIII 0.21
- MACD
- LSTA 0.01
- PIII 0.07
- Stochastic Oscillator
- LSTA 50.67
- PIII 33.33
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.